Duopharma Biotech Berhad (KLSE:DPHARMA)

Duopharma Biotech Berhad Balance Sheet

Financials in millions MYR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	258.85	264.55	270.5	157.64	137.98	158.03
Cash & Short-Term Investments	258.85	264.55	270.5	157.64	137.98	158.03
Cash Growth	11.42%	-2.20%	71.60%	14.25%	-12.69%	30.96%
Accounts Receivable	238.07	184.33	135.04	131.31	122.42	112.99
Other Receivables	19.11	23.59	26.38	10.84	10.31	22.18
Receivables	257.18	207.92	161.42	142.15	132.72	135.17
Inventory	244.05	248.55	243.07	235.18	222.19	151.27
Prepaid Expenses	-	5.39	2.08	6.52	1.9	0.67
Other Current Assets	-	-	-	-	-	14.56
Total Current Assets	760.08	726.4	677.07	541.49	494.8	459.69
Property, Plant & Equipment	563.36	567.52	582.37	579.92	542.53	441.79
Long-Term Investments	18.8	22.67	36.91	42.15	73.54	112.25
Other Intangible Assets	43.8	7.32	7.65	3.84	4.95	4.66
Long-Term Deferred Tax Assets	14.95	15.33	8.95	13.33	12.7	8.54
Long-Term Deferred Charges	-	37.55	31.15	40.14	34.58	30.41
Other Long-Term Assets	1.05	1.05	1.05	1.05	1.05	1.1
Total Assets	1,402	1,378	1,345	1,222	1,164	1,058
Accounts Payable	156.06	55.89	40.45	51.93	31.32	28.15
Accrued Expenses	-	46.92	33.79	40.46	61.2	45.62
Short-Term Debt	40.58	32.33	50.59	101.8	87.85	36.11
Current Portion of Long-Term Debt	-	15.66	14.95	32.34	15.08	12.68
Current Portion of Leases	-	0.55	0.92	0.94	0.64	0.6
Current Income Taxes Payable	1.69	0.74	0.37	1.17	6.06	0.74
Other Current Liabilities	-	25.89	25.65	35.95	28.17	26.41
Total Current Liabilities	198.33	177.99	166.73	264.59	230.31	150.32
Long-Term Debt	460.32	464.52	480.9	294.6	297.8	253.28
Long-Term Leases	-	2.76	1.48	1.92	2.48	0.66
Long-Term Deferred Tax Liabilities	29.12	23.42	8.91	5.58	9.54	10.35
Total Liabilities	690.27	668.68	658.01	566.7	540.13	414.61
Common Stock	432.47	432.47	432.47	419.37	405.86	404.92
Retained Earnings	361.18	354.78	319.07	288.37	239.97	220.18
Comprehensive Income & Other	-81.89	-78.09	-64.41	-52.52	-21.82	18.72
Shareholders' Equity	711.75	709.15	687.12	655.22	624	643.82
Total Liabilities & Equity	1,402	1,378	1,345	1,222	1,164	1,058
Total Debt	500.9	515.82	548.85	431.6	403.84	303.33
Net Cash (Debt)	-242.05	-251.28	-278.35	-273.97	-265.86	-145.31
Net Cash Per Share	-0.25	-0.26	-0.29	-0.29	-0.29	-0.16
Filing Date Shares Outstanding	960.3	961.94	961.94	952.24	941.77	941.37
Total Common Shares Outstanding	960.3	961.94	961.94	952.24	941.77	941.37
Working Capital	561.75	548.42	510.34	276.9	264.49	309.37
Book Value Per Share	0.74	0.74	0.71	0.69	0.66	0.68
Tangible Book Value	667.96	701.84	679.47	651.38	619.06	639.16
Tangible Book Value Per Share	0.70	0.73	0.71	0.68	0.66	0.68
Land	-	65.68	65.68	69.88	69.88	69.88
Buildings	-	267.09	265.86	125.23	124.51	119.57
Machinery	-	452.39	435.18	368.47	308.94	291.64
Construction In Progress	-	12.19	8.48	172.65	162.63	65.81

Updated Feb 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.